The T47D cell line represents the luminal A subtype of breast cancer, characterized by positivity for estrogen receptor (ER+) and progesterone receptor (PR+) and human epidermal growth factor receptor 2 (HER2-) (Ahmed et al., 2022). Here, ERBB2 is linked to breast carcinoma.